Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Baxter
AstraZeneca
Mallinckrodt
McKinsey

Last Updated: January 21, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Senicapoc


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Senicapoc?

Senicapoc is an investigational drug.

There have been 5 clinical trials for Senicapoc. The most recent clinical trial was a Phase 2 trial, which was initiated on April 24th 2020.

The most common disease conditions in clinical trials are Asthma, Anemia, Hemolytic, Congenital, and Alzheimer Disease. The leading clinical trial sponsors are Icagen, Odense University Hospital, and University of Aarhus.

Recent Clinical Trials for Senicapoc
TitleSponsorPhase
Senicapoc in Alzheimer's DiseaseUniversity of California, DavisPhase 2
Senicapoc and Dehydrated StomatocytosisQuest DiagnosticsPhase 1/Phase 2
Senicapoc and Dehydrated StomatocytosisBoston Children's HospitalPhase 1/Phase 2

See all Senicapoc clinical trials

Clinical Trial Summary for Senicapoc

Top disease conditions for Senicapoc
Top clinical trial sponsors for Senicapoc

See all Senicapoc clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Baxter
AstraZeneca
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.